June 18, 2021
An authorized generic (AG) version of Takeda Pharmaceutical’s hypertension drug Zacras (azilsartan + amlodipine) hit the market on June 18 upon its NHI price listing. The AG version, called ZilMlo, was introduced by Teva Takeda Pharma, which announced the launch...read more